Untech selected for Acelerar España Program by Insud Pharma

Untech was selected to participate in the Acelerar España, an initiative led by Insud Pharma to support high-potential healthcare ventures. As part of the program, Untech engaged directly with industry leaders and presented key advancements in the development of its chronic wound therapy.

During the program, the team had the opportunity to share progress alongside Hugo Sigman, reinforcing the strategic relevance of Untech’s innovation within the global pharmaceutical ecosystem. The experience further strengthens Untech’s positioning as a high-impact company with strong potential for international growth and partnerships.